ArticleiScience2026

Aberrant CDK4/6-driven cell-cycle reentry drives neuronal loss and defines a therapeutic target in C9orf72 ALS/FTD.

Ling Lian et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.